Flerie Completes Biosergen Merger, Issues 2.67 Million Shares
Flerie transferred all Biosergen assets and liabilities to Flerie as merger consideration. It issued 2,667,234 new shares, bringing share capital to SEK 196.6 million across 89,364,936 ordinary shares.
Flerie has completed its merger with Biosergen, transferring all of Biosergen’s assets and liabilities to Flerie. As consideration, Flerie issued 2667234 new shares. Following the issuance, share capital stands at SEK 196.6M, divided among 89364936 ordinary shares.